FDA Food and Drug Administration

FDA approves new pain medicine

FDA approves 1st new class of opioid-free painkillers in over 20 years

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

USA TODAY on MSN · 7h

FDA approves new pain medication as an alternative to opioids: What to know about Journavx

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

BGR · 3h

FDA approved the first new kind of pain medication in 27 years. Here’s how it works

The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its root.

FDA, Recall and Chocolate

AOL · 1h

Chocolate Recall Updated to Highest Risk Level, FDA Warns Consumption Could Cause Death

Cal Yee Farms' dark chocolate walnuts, dark chocolate almonds and dark chocolate apricots have been given a Class 1 recall classification because the chocolates contained undeclared milk

YAHOO!News · 4h

Chocolate recall elevated by FDA on products sold in Tennessee. Here's what to know

The Food and Drug Administration pushed a recall by the California-based company on multiple chocolate, yogurt and other products distributed by it due to certain allergens not being listed on the products that could cause life-threatening reactions if ingested.

MLive · 1d

This chocolate recall has been upgraded to FDA’s highest risk level

A December 2024 chocolate recall has been upgraded to highest risk level by the U.S. Food and Drug Administration (FDA), which says consuming the product could “cause serious adverse health consequences or death.

FDA, Axsome and migraine

Reuters · 23h

US FDA approves Axsome Therapeutics' migraine drug

The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.

Business Insider · 1d

Axsome Therapeutics announces FDA approval of Symbravo

Axsome Therapeutics (AXSM) announced that the U.S. FDA has approved Symbravo for the acute treatment of migraine with or without aura in

Investing.com on MSN · 1d

FDA approves new migraine treatment SYMBRAVO

NEW YORK - Axsome Therapeutics, Inc. (NASDAQ:AXSM), a $5.28 billion biopharmaceutical company with impressive 51% revenue growth over the last twelve months, announced the U.S. Food and Drug Administration (FDA) has approved SYMBRAVO®,

1hon MSN

Full List of Food Recalls in January as Warnings Issued Nationwide

Severe food sensitivities and allergies affect millions of Americans, according to the FDA. The nine "major" food allergens ...

JD Supra2h

FDA Bans Red Dye No. 3 in Food and Ingested Drugs: What Manufacturers Should Know

On January 16, 2025, the Food and Drug Administration (FDA) issued an order banning FD&C Red No.3 in food and ingested drugs.1 Food and ingested ...

The American Journal of Managed Care48m

FDA Quietly Removes Draft Guidance on Diversity in Clinical Trials Following Executive Order on DEI

The FDA removed previously issued draft guidance on diversity in clinical trials from its website without public notice or ...

4mon MSN

About half of Americans approve of using weight-loss drugs to treat obesity, new poll finds

New poll shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs if they are ...

Healio8m

FDA recalls Mercury Medical T-piece resuscitator due to ventilation control component

The FDA has recalled Mercury Medical’s Neo-Tee T-Piece Resuscitator, a gas powered resuscitator intended primarily for ...

3hon MSN

Trump Has Created Health-Care Chaos

In the past two weeks, the Trump administration has spent a remarkable amount of time undoing health orders—not just the ...

Fact Check: No evidence FDA official arrested for having bird flu samples in his fridge

There is no evidence that a senior Food and Drug Administration (FDA) worker was arrested after samples of the H5N1 bird flu virus were found in his fridge. The narrative stems from a website whose ...

Roche Gets FDA Approval for Breast Cancer Test

The Swiss pharmaceutical company said the FDA backed a label expansion for the Pathway HER2 (4B5) test to identify patients with HR-positive, HER2-ultralow metastatic breast cancer who could be ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results